Home › RegulatoryJanux Therapeutics, Inc. - 10-Q FilingJanux Therapeutics reports quarterly results for the period ended September 30, 2026SEC EDGAR · November 5, 2026, 21:19 UTCTickers: $JANX Read the full article at SEC EDGAR